| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
ObesityDiabetes mellitus (BASKET)OrlistatGrowth hormoneDeep brain stimulationNon alcoholic steatohepatosisAdiponectinLeptinRBP4VisfatinAdipokineResistinKidney (Chronic renal failure)Bariatric surgeryEndocrine disruptorEstrogenSteatohepatosisInsulin resistanceArterial hypertension (BASKET)Ion channel (Sodium)Liddle s syndromeIon channel (Sodium ENaC)Neoplasia (Carcinogenesis)Interleukin17Inflammation resolutionLipoxinProstaglandin D2ProtectinResolvinAgoutiDb mouseNutrition (Neuroendocrinology)Neuropeptide YKrox20 Egr2Arcuate nucleusParaventricular nucleiDorsomedial nucleusVentromedial nucleusZucker ratKoletsky ratob ob mouseOtsuka Long Evans Tokushima fatty rat OLETF ratTubby mouseAutoantibodies Anti Melanocortin 4 receptorInflammation (BASKET)Inflammation homeostaticFatty acids (Free)Circadian clockAnorexia nervosaGhrelinCachexia (Oncology and BASKET)Prader Willi s syndromeFructoseA Zip F1 mouseNeoplasia (Cancer survivor)SibutramineRimonabantMacrophagesAtherosclerosis (BASKET)MIF | 1 | 2006 | The medical complications of obesity. | 
| + | - | nl | QJM 99(9):565-79 (2006) Malnick SD |
| 2 | 2006 | Preventing and managing pediatric obesity. Recommendations for family physicians. | 
| + | - | nl | Can Fam Physician 52():322-8 (2006) Plourde G |
| 3 | 2007 | Obesity in children. | 
| + | - | nl | Clin Evid (Online) 2007(): (2007) Arteburn DE |
| 4 | 2008 | Orlistat in the prevention of diabetes in the obese patient. | 
| + | - | nl | Vasc Health Risk Manag 4(2):325-36 (2008) Mancini MC |
| 5 | 2006 | Vascular risks and management of obesity in children and adolescents. | 
| + | - | nl | Vasc Health Risk Manag 2(2):171-87 (2006) Jolliffe CJ |
| 6 | 2007 | Pharmacological treatment of the overweight patient. | 
| + | - | nl | Pharmacol Rev 59(2):151-84 (2007) Bray GA |
| 7 | 2008 | Atherogenic lipid risk factors in men classified as overweight and obese according to the preliminary WHO guidelines for Asians. | 
| + | - | nl | Indian J Physiol Pharmacol 52(2):205-8 (2008) Nandeesha H |
| 8 | 2009 | The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. | 
| + | - | nl | Health Technol Assess 13(41):1-190, 215-357, iii-iv (2009) Picot J |
| 9 | 2008 | Obesity: a review of pathogenesis and management strategies. | 
| + | - | nl | Can J Gastroenterol 22(1):61-8 (2008) Kaila B |
| 10 | 2004 | Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. | 
| + | - | nl | Am J Clin Nutr 79(4):537-43 (2004) Bray GA |
| 11 | 1993 | Mechanisms by which somatotropin decreases adipose tissue growth. | 
| + | - | nl | Am J Clin Nutr 58(2 Suppl):287S-295S (1993) |
| 12 | 1992 | The role of very-low-calorie diets in obesity. | 
| + | - | nl | Am J Clin Nutr 56(1 Suppl):240S-243S (1992) |
| 13 | 1992 | Pathophysiology of obesity. | 
| + | - | nl | Am J Clin Nutr 55(2 Suppl):488S-494S (1992) |
| 14 | 1992 | A brief overview of human energy metabolism and its relationship to essential obesity. | 
| + | - | nl | Am J Clin Nutr 55(1 Suppl):242S-245S (1992) |
| 15 | 1979 | Obesity: adverse effects on health and longevity. | 
| + | - | nl | Am J Clin Nutr 32(12 Suppl):2723-33 (1979) |
| 16 | 2001 | Infectobesity: obesity of infectious origin. | 
| + | - | nl | J Nutr 131(10):2794S-2797S (2001) |
| 17 | 2005 | Obesity: prevalence, theories, medical consequences, management, and research directions. | 
| + | - | nl | J Int Soc Sports Nutr 2():4-31 (2005) Wilborn C |
| 18 | 2004 | Monogenic human obesity syndromes. | 
| + | - | nl | Recent Prog Horm Res 59():409-24 (2004) Farooqi IS |
| 19 | 2004 | Hypertension and obesity. | 
| + | - | nl | Recent Prog Horm Res 59():169-205 (2004) Aneja A |
| 20 | 2010 | Deep brain stimulation compared with bariatric surgery for the treatment of morbid obesity: a decision analysis study. | 
| + | - | nl | Neurosurg Focus 29(2):E15 (2010) Pisapia JM |
| 21 | 2008 | Adverse renal consequences of obesity. | 
| + | - | nl | Am J Physiol Renal Physiol 294(4):F685-96 (2008) Griffin KA |
| 22 | 2005 | Meta-analysis: surgical treatment of obesity. | 
| + | - | nl | Ann Intern Med 142(7):547-59 (2005) Maggard MA |
| 23 | 2005 | Meta-analysis: pharmacologic treatment of obesity. | 
| + | - | nl | Ann Intern Med 142(7):532-46 (2005) Li Z |
| 24 | 2008 | Association between depressive symptoms in childhood and adolescence and overweight in later life: review of the recent literature. | 
| + | - | nl | Arch Pediatr Adolesc Med 162(10):981-8 (2008) Liem ET |
| 25 | 2005 | Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. | 
| + | - | nl | Circulation 111(15):1999-2012 (2005) Daniels SR |
| 26 | 2007 | Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. | 
| + | - | nl | Clin J Am Soc Nephrol 2(3):550-62 (2007) Wahba IM |
| 27 | 2008 | Neurophysiological pathways to obesity: below awareness and beyond individual control. | 
| + | - | nl | Diabetes 57(7):1768-73 (2008) Cohen DA |
| 28 | 2006 | Influence of obesity on the risk of developing colon cancer. | 
| + | - | nl | Gut 55(2):285-91 (2006) Frezza EE |
| 29 | 2004 | New thoughts on managing obesity. | 
| + | - | nl | Gut 53(7):1044-53 (2004) Kopelman PG |
| 30 | 2008 | Clinical review: treatment of pediatric obesity: a systematic review and meta-analysis of randomized trials. | 
| + | - | nl | J Clin Endocrinol Metab 93(12):4600-5 (2008) McGovern L |
| 31 | 2008 | Clinical review: behavioral interventions to prevent childhood obesity: a systematic review and metaanalyses of randomized trials. | 
| + | - | nl | J Clin Endocrinol Metab 93(12):4606-15 (2008) Kamath CC |
| 32 | 2008 | Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion. | 
| + | - | nl | J Clin Endocrinol Metab 93(12):4576-99 (2008) August GP |
| 33 | 2008 | Obesity-associated liver disease. | 
| + | - | nl | J Clin Endocrinol Metab 93(11 Suppl 1):S74-80 (2008) |
| 34 | 2008 | Adipocytokines and the metabolic complications of obesity. | 
| + | - | nl | J Clin Endocrinol Metab 93(11 Suppl 1):S64-73 (2008) Rasouli N |
| 35 | 2008 | Obesity in children and adolescents. | 
| + | - | nl | J Clin Endocrinol Metab 93(11 Suppl 1):S31-6 (2008) |
| 36 | 2008 | Update on obesity. | 
| + | - | nl | J Clin Endocrinol Metab 93(6):2027-34 (2008) Bessesen DH |
| 37 | 2007 | Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism. | 
| + | - | nl | J Clin Endocrinol Metab 92(2):386-95 (2007) Sharma AM |
| 38 | 2005 | Childhood obesity. | 
| + | - | nl | J Clin Endocrinol Metab 90(3):1871-87 (2005) Speiser PW |
| 39 | 2004 | Childhood obesity. | 
| + | - | nl | J Clin Endocrinol Metab 89(9):4211-8 (2004) Miller J |
| 40 | 2004 | Medical consequences of obesity. | 
| + | - | nl | J Clin Endocrinol Metab 89(6):2583-9 (2004) Bray GA |
| 41 | 2001 | Obesity-related glomerulopathy: an emerging epidemic. | 
| + | - | nl | Kidney Int 59(4):1498-509 (2001) |
| 42 | 2007 | Evaluation and management of childhood and adolescent obesity. | 
| + | - | nl | Mayo Clin Proc 82(10):1258-64 (2007) Singhal V |
| 43 | 2007 | Viruses as an etiology of obesity. | 
| + | - | nl | Mayo Clin Proc 82(10):1192-8 (2007) Atkinson RL |
| 44 | 2007 | Surgery for morbid obesity. | 
| + | - | nl | Postgrad Med J 83(975):8-15 (2007) Bennett JM |
| 45 | 1988 | Obesity. Part II--Treatment. | 
| + | - | nl | West J Med 149(5):555-71 (1988) |
| 46 | 1988 | Obesity. Part I--Pathogenesis. | 
| + | - | nl | West J Med 149(4):429-41 (1988) |
| 47 | 2007 | Diseases associated with childhood obesity. | 
| + | - | nl | AJR Am J Roentgenol 188(4):1118-30 (2007) Choudhary AK |
| 48 | 2007 | Synopsis of the 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children. | 
| + | - | nl | CMAJ 176(8):1103-6 (2007) Lau DC |
| 49 | 2007 | 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. | 
| + | - | nl | CMAJ 176(8):S1-13 (2007) Lau DC |
| 50 | 2008 | The role of SOCS-3 protein in leptin resistance and obesity. | 
| + | - | nl | Acta Med Indones 40(2):89-95 (2008) |
| 51 | 2009 | Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review. | 
| + | - | nl | Am J Nephrol 30(2):140-6 (2009) |
| 52 | 2011 | Respiratory complications of obesity. | 
| + | - | nl | Arch Bronconeumol 47(5):252-61 (2011) |
| 53 | 2004 | Dietary supplements for body-weight reduction: a systematic review. | 
| + | - | nl | Am J Clin Nutr 79(4):529-36 (2004) |
| 54 | 2005 | Survival advantages of obesity in dialysis patients. | 
| + | - | nl | Am J Clin Nutr 81(3):543-54 (2005) |
| 55 | 2006 | Metabolic programming: fetal origins of obesity and metabolic syndrome in the adult. | 
| + | - | nl | Am J Physiol Endocrinol Metab 291(3):E439-40 (2006) |
| 56 | 2006 | ABC of obesity. Assessment of obesity and its clinical implications. | 
| + | - | nl | BMJ 333(7570):695-8 (2006) |
| 57 | 2006 | ABC of obesity. Management: Part I--behaviour change, diet, and activity. | 
| + | - | nl | BMJ 333(7571):740-3 (2006) |
| 58 | 2006 | ABC of obesity. Management: Part III--surgery. | 
| + | - | nl | BMJ 333(7574):900-3 (2006) |
| 59 | 2006 | ABC of obesity. Management: part II--drugs. | 
| + | - | nl | BMJ 333(7572):794-7 (2006) |
| 60 | 2006 | ABC of obesity. Strategies for preventing obesity. | 
| + | - | nl | BMJ 333(7575):959-62 (2006) |
| 61 | 2006 | ABC of obesity. Obesity and cancer. | 
| + | - | nl | BMJ 333(7578):1109-11 (2006) |
| 62 | 2006 | ABC of obesity: obesity and vascular disease. | 
| + | - | nl | BMJ 333(7577):1060-3 (2006) |
| 63 | 2006 | ABC of obesity. Risk factors for diabetes and coronary heart disease. | 
| + | - | nl | BMJ 333(7576):1009-11 (2006) |
| 64 | 2006 | ABC of obesity. Childhood obesity. | 
| + | - | nl | BMJ 333(7580):1207-10 (2006) |
| 65 | 2006 | ABC of obesity. Obesity and reproduction. | 
| + | - | nl | BMJ 333(7579):1159-62 (2006) |
| 66 | 2009 | Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors. | 
| + | - | nl | Biochim Biophys Acta 1793(7):1128-43 (2009) |
| 67 | 2006 | Tending to the musculoskeletal problems of obesity. | 
| + | - | nl | Cleve Clin J Med 73(9):839-45 (2006) |
| 68 | 2003 | Prevention of pediatric overweight and obesity. | 
| + | - | nl | Pediatrics 112(2):424-30 (2003) |
| 69 | 2007 | Assessment of child and adolescent overweight and obesity. | 
| + | - | nl | Pediatrics 120 Suppl 4(-):S193-228 (2007) |
| 70 | 2007 | Recommendations for prevention of childhood obesity. | 
| + | - | nl | Pediatrics 120 Suppl 4(-):S229-53 (2007) |
| 71 | 2007 | Recommendations for treatment of child and adolescent overweight and obesity. | 
| + | - | nl | Pediatrics 120 Suppl 4(-):S254-88 (2007) |
| 72 | 2009 | Spectrum and management of hypertriglyceridemia among children in clinical practice. | 
| + | - | nl | Pediatrics 123(2):458-65 (2009) |
| 73 | 2007 | Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. | 
| + | - | nl | World J Gastroenterol 13(26):3540-53 (2007) |
| 74 | 2007 | Treatment of obesity. | 
| + | - | nl | Mayo Clin Proc 82(1):93-101; quiz 101-2 (2007) |
| 75 | 2007 | Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. | 
| + | - | nl | Physiology (Bethesda) 22(-):252-60 (2007) |
| 76 | 2010 | Sympathetic activation in obesity: a noninnocent bystander. | 
| + | - | nl | Hypertension 56(3):338-40 (2010) |
| 77 | 2002 | Obesity hypertension in children: a problem of epidemic proportions. | 
| + | - | nl | Hypertension 40(4):441-7 (2002) |
| 78 | 2010 | Obesity, sympathetic overdrive, and hypertension: the leptin connection. | 
| + | - | nl | Hypertension 55(4):844-5 (2010) |
| 79 | 2007 | Hypoadiponectinemia: a novel link between obesity and hypertension? | 
| + | - | nl | Hypertension 49(6):1217-9 (2007) |
| 80 | 2008 | Should we target the sympathetic nervous system in the treatment of obesity-associated hypertension? | 
| + | - | nl | Hypertension 51(2):168-71 (2008) |
| 81 | 2004 | Overview: obesity: what does it have to do with kidney disease? | 
| + | - | nl | J Am Soc Nephrol 15(11):2768-72 (2004) |
| 82 | 2004 | Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease? | 
| + | - | nl | J Am Soc Nephrol 15(11):2775-91 (2004) |
| 83 | 2004 | The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. | 
| + | - | nl | J Am Soc Nephrol 15(11):2792-800 (2004) |
| 84 | 2003 | After all those fat years: renal consequences of obesity. | 
| + | - | nl | Nephrol Dial Transplant 18(12):2471-4 (2003) |
| 85 | 2008 | Why is obesity associated with osteoarthritis? Insights from mouse models of obesity. | 
| + | - | nl | Biorheology 45(3-4):387-98 (2008) |
| 86 | 2010 | Endoplasmic reticulum stress and inflammation in obesity and diabetes. | 
| + | - | nl | Circ Res 107(5):579-91 (2010) |
| 87 | 2007 | Cardiac energy metabolism in obesity. | 
| + | - | nl | Circ Res 101(4):335-47 (2007) |
| 88 | 2007 | Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals. | 
| + | - | nl | Circ Res 101(1):27-39 (2007) |
| 89 | 2007 | Leptin signaling and obesity: cardiovascular consequences. | 
| + | - | nl | Circ Res 101(6):545-59 (2007) |
| 90 | 2011 | Biology of obesity: lessons from animal models of obesity. | 
| + | - | nl | J Biomed Biotechnol 2011(-):197636 (2011) |
| 91 | 2006 | Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 26(5):968-76 (2006) |
| 92 | 2010 | Epithelial Na+ channel (ENaC), hormones, and hypertension. | 
| + | - | nl | J Biol Chem 285(31):23527-31 (2010) |
| 93 | 2010 | The possible role of IL-17 in obesity-associated cancer. | 
| + | - | nl | ScientificWorldJournal 10(-):2265-71 (2010) |
| 94 | 2010 | Resolution of adipose tissue inflammation. | 
| + | - | nl | ScientificWorldJournal 10(-):832-56 (2010) |
| 95 | 2006 | Neuropeptide Y in normal eating and in genetic and dietary-induced obesity. | 
| + | - | nl | Philos Trans R Soc Lond B Biol Sci 361(1471):1159-85 (2006) |
| 96 | 2006 | Genetics of obesity. | 
| + | - | nl | Philos Trans R Soc Lond B Biol Sci 361(1471):1095-105 (2006) O'Rahilly S |
| 97 | 2008 | Role of body fat distribution and the metabolic complications of obesity. | 
| + | - | nl | J Clin Endocrinol Metab 93(11 Suppl 1):S57-63 (2008) |
| 98 | 2008 | Lifestyle and pharmacological approaches to weight loss: efficacy and safety. | 
| + | - | nl | J Clin Endocrinol Metab 93(11 Suppl 1):S81-8 (2008) |
| 99 | 2008 | Bariatric surgery: risks and rewards. | 
| + | - | nl | J Clin Endocrinol Metab 93(11 Suppl 1):S89-96 (2008) |
| 100 | 2009 | Melanocortin-4-receptor autoantibodies: a new player in obesity. | 
| + | - | nl | J Clin Endocrinol Metab 94(3):757-9 (2009) Mohan C |
| 101 | 2010 | Homeostatic inflammation, an emerging concept. | 
| + | - | nl | Endocr J 57(8):657-8 (2010) |
| 102 | 2008 | Obesity and free fatty acids. | 
| + | - | nl | Endocrinol Metab Clin North Am 37(3):635-46, viii-ix (2008) |
| 103 | 2009 | Pediatric obesity: etiology and treatment. | 
| + | - | nl | Endocrinol Metab Clin North Am 38(3):525-48 (2009) |
| 104 | 2010 | Metabolism and circadian rhythms--implications for obesity. | 
| + | - | nl | Endocr Rev 31(1):1-24 (2010) |
| 105 | 2011 | Ghrelin biology and its role in weight-related disorders. | 
| + | - | nl | Discov Med 11(61):521-8 (2011) |
| 106 | 2011 | Genetic approaches to understanding human obesity. | 
| + | - | nl | J Clin Invest 121(6):2080-6 (2011) |
| 107 | 2011 | Adipose tissue remodeling and obesity. | 
| + | - | nl | J Clin Invest 121(6):2094-101 (2011) |
| 108 | 2011 | Inflammatory links between obesity and metabolic disease. | 
| + | - | nl | J Clin Invest 121(6):2111-7 (2011) |
| 109 | 2010 | Metabolic effects of fructose and the worldwide increase in obesity. | 
| + | - | nl | Physiol Rev 90(1):23-46 (2010) |
| 110 | 2008 | Cardiac remodeling in obesity. | 
| + | - | nl | Physiol Rev 88(2):389-419 (2008) |
| 111 | 2010 | JNK1 and IKKbeta: molecular links between obesity and metabolic dysfunction. | 
| + | - | nl | FASEB J 24(8):2596-611 (2010) |
| 112 | 2007 | The obesity-cancer link: lessons learned from a fatless mouse. | 
| + | - | nl | Cancer Res 67(6):2391-3 (2007) |
| 113 | 2006 | Obesity in childhood and adolescence: evidence based clinical and public health perspectives. | 
| + | - | nl | Postgrad Med J 82(969):429-37 (2006) |
| 114 | 2003 | Principles and practices in the management of obesity. | 
| + | - | nl | Am J Respir Crit Care Med 168(3):274-80 (2003) |
| 115 | 2006 | Pharmacological treatment of obesity. | 
| + | - | nl | Arq Bras Endocrinol Metabol 50(2):377-89 (2006) |
| 116 | 2009 | Genetic variants influencing effectiveness of weight loss strategies. | 
| + | - | nl | Arq Bras Endocrinol Metabol 53(2):129-38 (2009) |
| 117 | 2009 | Translational research into gut microbiota: new horizons in obesity treatment. | 
| + | - | nl | Arq Bras Endocrinol Metabol 53(2):139-44 (2009) |
| 118 | 2009 | The brain is the conductor: diet-induced inflammation overlapping physiological control of body mass and metabolism. | 
| + | - | nl | Arq Bras Endocrinol Metabol 53(2):151-8 (2009) |
| 119 | 2009 | Infeccions as the etiology for obesity. | 
| + | - | nl | Arq Bras Endocrinol Metabol 53(2):159-64 (2009) |
| 120 | 2009 | Impact of adiposity on immunological parameters. | 
| + | - | nl | Arq Bras Endocrinol Metabol 53(2):183-9 (2009) |
| 121 | 2009 | Adiposity in childhood cancer survivors: insights into obesity physiopathology. | 
| + | - | nl | Arq Bras Endocrinol Metabol 53(2):190-200 (2009) |
| 122 | 2009 | Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications. | 
| + | - | nl | Arq Bras Endocrinol Metabol 53(2):201-12 (2009) |
| 123 | 2009 | Epidemiological and molecular mechanisms aspects linking obesity and cancer. | 
| + | - | nl | Arq Bras Endocrinol Metabol 53(2):213-26 (2009) |
| 124 | 2009 | Metabolic disturbances linked to obesity: the role of impaired tissue perfusion. | 
| + | - | nl | Arq Bras Endocrinol Metabol 53(2):238-45 (2009) |
| 125 | 2009 | Management of obesity in adolescents: state of art. | 
| + | - | nl | Arq Bras Endocrinol Metabol 53(2):252-61 (2009) |
| 126 | 2009 | The first decade of sibutramine and orlistat: a reappraisal of their expanding roles in the treatment of obesity and associated conditions. | 
| + | - | nl | Arq Bras Endocrinol Metabol 53(2):262-70 (2009) |
| 127 | 2009 | Emerging drugs for obesity therapy. | 
| + | - | nl | Arq Bras Endocrinol Metabol 53(2):271-80 (2009) |
| 128 | 2011 | Bariatric surgery. | 
| + | - | nl | Dtsch Arztebl Int 108(20):341-6 (2011) |
| 129 | 2006 | The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies. | 
| + | - | nl | CMAJ 174(9):1293-9 (2006) |
| 130 | 2004 | 10: Management of obesity. | 
| + | - | nl | Med J Aust 180(9):474-80 (2004) |
| 131 | 2011 | The clinical effectiveness and cost-effectiveness of long-term weight management schemes for adults: a systematic review. | 
| + | - | nl | Health Technol Assess 15(2):1-182 (2011) |
| 132 | 2009 | Rimonabant for the treatment of overweight and obese people. | 
| + | - | nl | Health Technol Assess 13 Suppl 3(-):13-22 (2009) |
| 133 | 2009 | Rimonabant: an antagonist drug of the endocannabinoid system for the treatment of obesity. | 
| + | - | nl | Pharmacol Rep 61(2):217-24 (2009) |
| 134 | 2007 | Adolescent overweight and obesity--how best to manage in the general practice setting. | 
| + | - | nl | Aust Fam Physician 36(8):606-12 (2007) |
| 135 | 2010 | Obesity in children & adolescents. | 
| + | - | nl | Indian J Med Res 132(5):598-607 (2010) |
| 136 | 2010 | The adverse effects of obesity on conception and implantation. | 
| + | - | nl | Reproduction 140(3):347-64 (2010) |
| 137 | 2007 | Developmental programming of obesity in mammals. | 
| + | - | nl | Exp Physiol 92(2):287-98 (2007) |
| 138 | 2005 | The neurobiology of human obesity. | 
| + | - | nl | Exp Physiol 90(5):673-82 (2005) |
| 139 | 2005 | Role of leptin in obesity-related hypertension. | 
| + | - | nl | Exp Physiol 90(5):683-8 (2005) |
| 140 | 2009 | Medical management of obesity and its complications. | 
| + | - | nl | Ann Acad Med Singapore 38(1):22-7 (2009) |
| 141 | 2009 | Endocrine disrupters as obesogens. | 
| + | - | nl | Mol Cell Endocrinol 304(1-2):19-29 (2009) |
| 142 | 2009 | Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndrome. | 
| + | - | nl | Mol Cell Endocrinol 304(1-2):49-54 (2009) |
| 143 | 2010 | Hormones and cytokines in childhood obesity. | 
| + | - | nl | Indian Pediatr 47(10):829-39 (2010) |
| 144 | 2010 | Mediators of inflammation in obesity and its comorbidities. | 
| + | - | nl | Mediators Inflamm 2010(-):- (2010) |
| 145 | 2010 | The role of adipose tissue and adipokines in obesity-related inflammatory diseases. | 
| + | - | nl | Mediators Inflamm 2010(-):802078 (2010) |
| 146 | 2010 | Chronic inflammation in obesity and the metabolic syndrome. | 
| + | - | nl | Mediators Inflamm 2010(-):- (2010) |
| 147 | 2010 | Inflammatory mediators and insulin resistance in obesity: role of nuclear receptor signaling in macrophages. | 
| + | - | nl | Mediators Inflamm 2010(-):219583 (2010) |
| 148 | 2010 | Functional food targeting the regulation of obesity-induced inflammatory responses and pathologies. | 
| + | - | nl | Mediators Inflamm 2010(-):367838 (2010) |
| 149 | 2010 | Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review. | 
| + | - | nl | Mediators Inflamm 2010(-):513948 (2010) |
| 150 | 2010 | Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells. | 
| + | - | nl | Mediators Inflamm 2010(-):174341 (2010) |
| 151 | 2010 | Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients. | 
| + | - | nl | Mediators Inflamm 2010(-):364957 (2010) |
| 152 | 2010 | Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities. | 
| + | - | nl | Mediators Inflamm 2010(-):610479 (2010) |
| 153 | 2008 | Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. | 
| + | - | nl | Nat Rev Mol Cell Biol 9(5):367-77 (2008) |